Financial News
Headline News about ARS Pharmaceuticals, Inc. - Common Stock
Where ARS Pharmaceuticals Stands With Analysts
October 08, 2024
Via Benzinga
Analyst Ratings For ARS Pharmaceuticals
September 09, 2024
Via Benzinga
Looking Into ARS Pharmaceuticals's Recent Short Interest
August 19, 2024
Via Benzinga
ARS Pharma Readies Data In Response To FDA's Rejection For Its EpiPen Alternative For Severe Allergic Reactions
February 20, 2024
Via Benzinga
Exposures
Product Safety
Big Stocks Moving Higher On Friday: Synaptics Reports Q1 Beat; Joins Lyft, Hologic, Blink Charging
November 10, 2023
Via Benzinga
Topics
Stocks
Exposures
US Equities
Fisker, Intercept Pharmaceuticals, Immunovant And Other Big Stocks Moving Higher On Tuesday
September 26, 2023
Via Benzinga
Topics
Stocks
Exposures
US Equities
More Than $8M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying
September 26, 2023
Via Benzinga
Topics
Stocks
Exposures
US Equities
ARS Pharmaceuticals' EpiPen Alternative Delayed US Approval - Two Analysts Offer Differing Views
September 21, 2023
Via Benzinga
Exposures
Product Safety
12 Health Care Stocks Moving In Thursday's Intraday Session
September 21, 2023
Via Benzinga
Gold Moves Higher; Fed Leaves Key Overnight Interest Rate Unchanged
September 20, 2023
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
September 20, 2023
Via Benzinga
Nasdaq Turns Lower; Cambridge Bancorp Shares Surge
September 20, 2023
Via Benzinga
Topics
Stocks
Exposures
US Equities
Benzinga's Top Ratings Upgrades, Downgrades For September 20, 2023
September 20, 2023
Via Benzinga
Dow Gains 150 Points; General Mills Posts Upbeat Earnings
September 20, 2023
Via Benzinga
Topics
Stocks
Exposures
US Equities
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.